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SCIENTIFIC OPINION 
Statement on the update of the list of QPS-recommended biological agents 
intentionally added to food or feed as notified to EFSA 1: Suitability of 
taxonomic units notified to EFSA until October 2014
1
 
EFSA Panel on Biological Hazards (BIOHAZ)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy 
 
ABSTRACT 
EFSA is requested to assess the safety of a broad range of biological agents in the context of notifications for 
market authorisation as sources of food and feed additives, enzymes and plant protection products. The qualified 
presumption of safety (QPS) assessment was developed to provide a harmonised generic pre-assessment to 
support safety risk assessments performed by EFSA’s scientific Panels. The safety of unambiguously defined 
biological agents (at the highest taxonomic unit appropriate for the purpose for which an application is intended), 
and the completeness of the body of knowledge are assessed. Identified safety concerns for a taxonomic unit are, 
where possible and reasonable in number, reflected as ‘qualifications’ in connection with a recommendation for 
a QPS status. A total of 99 biological agents were notified to EFSA between May 2013 and October 2014. From 
those, 26 biological agents already had a QPS status and were not further evaluated, and 54 were also not 
included as they are filamentous fungi or enterococci, biological groups which have been excluded from the QPS 
activities since 2014. The remaining 19 notifications were considered for the assessment of the suitability for the 
QPS list. These 19 notifications referred to 13 taxonomic units which were evaluated for the QPS status, three of 
which were recommended for the QPS list: a) Carnobacterium divergens, with the qualification of absence of 
acquired antibiotic resistance determinants; b) Microbacterium imperiale, only for enzyme production, and 
c) Candida cylindracea, only for enzyme production. 
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SUMMARY 
The European Food Safety Authority (EFSA) asked the Panel on Biological Hazards (BIOHAZ) to 
deliver a Scientific Opinion on the maintenance of the list of QPS biological agents intentionally 
added to food or feed (2013 update). The question included three specific tasks in the terms of 
reference (ToR).  
The BIOHAZ Panel decided to change the evaluation procedure: the publication of the overall 
assessment of the taxonomic units previously recommended for the QPS list (EFSA, 2013) will be 
carried out after three years in a scientific opinion of the BIOHAZ Panel (December 2016) but in any 
case, that list of microorganisms will be maintained and frequently checked based on the evaluation of 
extensive literature reviews which will be updated regularly with new publications. Intermediate 
deliverables in the form of a Panel statement will be produced and published, should an assessment for 
a QPS classification of a microbiological agent notified to EFSA be requested by the Feed Unit, the 
Food Ingredients and Packaging (FIP) Unit, the Nutrition Unit and by the Pesticides Unit. Evaluations 
of these notifications will be compiled in a single statement for periods of around six months. The 
results of these assessments will also be included in the scientific opinion of the BIOHAZ Panel to be 
published until December of 2016. The “2013 updated list of QPS status recommended biological 
agents for safety risk assessments carried out by EFSA scientific Panels and Units”, will be appended 
to each Panel statement. New biological agents recommended for the QPS status will be included in 
that list, after the assessment of the new notifications evaluated for each Panel statement. 
The first ToR required to keep updated the list of biological agents being notified, in the context of a 
technical dossier to EFSA Units (such as Feed, Food Ingredients and Packaging (FIP), Nutrition and 
Pesticides), for intentional use in feed and/or food or as sources of food and feed additives, enzymes 
and plant protection products for safety assessment. The list was updated with the notifications 
received since the last review and it is appended to the current statement. Notifications considered for 
the current statement were received between May 2013 and October 2014. Within this period, 
99 notifications were received from those four Units, of which, 47 from Feed, 44 from FIP, 3 from 
Nutrition and 5 from Pesticides.   
The second ToR concerns the revision of the taxonomic units previously recommended for the QPS 
list and their qualifications (especially the qualification regarding antimicrobial resistance) when new 
information has become available and to update the information provided in the previous opinion 
(EFSA, 2013) where appropriate. The work being developed in order to reply to this ToR is not 
reflected in the current statement, but will be published in a scientific Opinion of the BIOHAZ Panel 
until December of 2016 as previously mentioned. 
The third ToR required a (re)assessment of the suitability of taxonomic units notified to EFSA not 
present in the current QPS list for their inclusion in the updated list. The current statement focusses on 
this ToR by including the individual assessments of the taxonomic units not previously included in the 
2013 QPS list. Of those 99 notifications received, 26 biological agents already had a QPS status and 
were not further evaluated in this statement. From the remaining 73 (without a QPS status), 54 were 
not further assessed as they are filamentous fungi or enterococci, biological groups which have been 
excluded from QPS activities since 2014 and 19 were considered for the assessment of the suitability 
of the respective taxonomic units for inclusion for the QPS list. Sixteen species were notified to the 
Feed Unit, 2 to the FIP Unit and one to the Nutrition Unit. The respective taxonomic units (13 in total) 
were assessed for their suitability for the QPS list. Of a total of 12 bacterial taxonomical units 
evaluated, 10 were notified to the Feed Unit (Actinomadura roseorufa, Bacillus toyonensis (previously 
B. cereus var. toyoi), Carnobacterium divergens, Clostridium butyricum, Escherichia coli, 
Paenibacillus lentus, Streptomyces albus, Streptomyces aureofaciens, Streptomyces lasaliensis, 
Streptomyces cinnamonensis), one to the FIP Unit (Microbacterium imperiale) and one to the 
Nutrition Unit (Bacteroides xylanisolvens). The only yeast taxonomic unit evaluated was notified to 
the FIP Unit (Candida cylindracea). After the assessment, which is included in the current statement, 
three taxonomic units were recommended for the QPS list: a) Carnobacterium divergens, with the 
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qualification of absence of acquired antibiotic resistance determinants; b) Microbacterium imperiale, 
only for enzyme production, and c) Candida cylindracea, only for enzyme production.  
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BACKGROUND AS PROVIDED BY EFSA 
A wide variety of microorganisms (including viruses) are intentionally added at different stages into 
the food chain, either directly or as a source of additives or food enzymes or plant protection products. 
EFSA is requested to assess the safety of these biological agents in the context of applications for 
market authorisation as sources of food and feed additives, enzymes and plant protection products 
received by EFSA.  
The Scientific Committee reviewed the range and numbers of microorganisms likely to be the subject 
of an EFSA Opinion and in 2007 published a list of microorganisms recommended for Qualified 
Presumption of Safety (QPS list),
4,5
 consisting of 48 species of Gram-positive non-sporulating 
bacteria, 13 Bacillus species and 11 yeast species. Filamentous fungi were also assessed but these 
were not recommended for QPS status. The Scientific Committee recommended that a QPS approach 
should be implemented across EFSA and applied equally to all safety considerations of 
microorganisms that EFSA is required to assess. The Scientific Committee recognised that there 
would have to be continuous provision for reviewing and modifying the QPS list. The EFSA Panel on 
Biological Hazards (BIOHAZ) took the prime responsibility for this and annually reviewed the 
existing QPS list, as recommended by the Scientific Committee. 
In the first annual QPS review and update,
6
 the existing QPS list was reviewed and EFSA’s initial 
experience in applying the QPS approach was described. The potential application of the QPS 
approach to microbial plant protection products was discussed in the 2009 review.
7
 In 2009, viruses 
and bacteriophages were assessed for the first time, leading to the addition of two virus families used 
for plant protection purposes to the QPS list. Bacteriophages were not considered appropriate for the 
QPS list. After consecutive years of updating the existing scientific knowledge, the filamentous fungi 
(2008 to 2013 update) and enterococci (2010-2013 update) were not recommended for the QPS list.  
The 2013 update of the recommended QPS list includes 53 species of Gram-positive non-sporulating 
bacteria, 13 Gram-positive spore forming bacteria (Bacillus species), 1 Gram-negative bacterium 
(Gluconobacter oxydans), 13 yeast species, and 3 virus families. No QPS recommended species has 
been taken down from the list following six (2008-2013 update) annual reviews.  
Based on the above mentioned information, the BIOHAZ Panel at their plenary meeting in January 
2014, made a proposal for future QPS activities that was discussed at the Scientific Committee 
meeting in February 2014. The Scientific Committee agreed to exclude some biological groups 
(filamentous fungi, bacteriophages and enterococci) in future QPS activities, while an extensive 
literature review of the QPS recommended list could be done less frequently. The deadline for the 
assessment of the suitability of new taxonomic units notified to EFSA for inclusion in the QPS list 
would be tailored to the needs of the requesting EFSA Units and/or Scientific Panels. 
TERMS OF REFERENCE AS PROVIDED BY EFSA 
ToR 1: Keep updated the list of biological agents being notified, in the context of a technical dossier to 
EFSA Units (such as Feed, Pesticides, Food Ingredients and Packaging, and Nutrition), for intentional 
use in feed and/or food or as sources of food and feed additives, enzymes and plant protection 
products for safety assessment.  
                                                     
4  Opinion of the Scientific Committee on a request from EFSA related to a generic approach to the safety assessment by 
EFSA of microorganisms used in food/feed and the production of food/feed additives. The EFSA Journal 2005, 226, 1-12.  
5 Introduction of a Qualified Presumption of Safety (QPS) approach for assessment of selected microorganisms referred to 
EFSA - Opinion of the Scientific Committee. The EFSA Journal 2007, 293, 1-85.  
6  Scientific Opinion of the Panel on Biological Hazards on a request from EFSA on the maintenance of the list of QPS 
microorganisms intentionally added to food or feed. The EFSA Journal 2008, 923, 1-48.  
7  Scientific Opinion of the Panel on Biological Hazards (BIOHAZ) on the maintenance of the list of QPS microorganisms 
intentionally added to food or feed (2009 update). EFSA Journal 2009; 7(12):1431, 92 pp. doi:10.2903/j.efsa.2009.1431. 
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ToR 2: Review taxonomic units previously recommended for the QPS list and their qualifications 
(especially the qualification regarding antimicrobial resistance) when new information has become 
available. Update the information provided in the previous opinion where appropriate. 
ToR 3: (Re) assess the suitability of taxonomic units notified to EFSA not present in the current QPS 
list for their inclusion in that list. 
BIOHAZ statement on QPS: suitability of taxonomic units notified to October 2014 
 
EFSA Journal 2014;12(12):3938 7 
EVALUATION 
1. Introduction 
A wide variety of microorganisms (including viruses) are intentionally added at different stages into 
the food chain, either directly or as a source of food and feed additives, enzymes or plant protection 
products. In the context of applications for market authorisation of these biological agents, EFSA is 
requested to assess their safety.  
Qualified Presumption of Safety (QPS) entered EU law with the publication of a new Commission 
Implementing Regulation (EU) No 562/2012
8
 amending Commission Regulation (EU) No 234/2011
9
 
with regard to specific data required for risk assessment of food enzymes. If the microorganism used 
in the production of a food enzyme has a status of QPS according to the most recent list of QPS 
recommended biological agents adopted by the European Food Safety Authority (EFSA), the enzyme 
application should not be required to include toxicological data. If residues, impurities and degradation 
products linked to the total enzyme production process (production, recovery and purification) could 
give rise for concern, the Authority, pursuant to Article 6(1) of Regulation (EC) No 1331/2008,
10
 may 
request additional data for risk assessment, including toxicological data. 
The QPS approach was developed by the Scientific Committee to provide a generic concept to 
prioritise and to harmonise risk assessment within EFSA of microorganisms intentionally introduced 
into the food chain, in support of the respective Scientific Panels and Units in the frame of 
authorisations (Butaye et al., 2003). The list, first established in 2007 has been revised and updated. 
Taxonomic units were included in the QPS list either following notifications to EFSA or following 
proposals made by stakeholders during a public consultation in 2005, even if they were not yet 
notified to EFSA (EFSA BIOHAZ Panel, 2013). For the 2014 update, it was decided to change the 
procedures. The publication of the overall assessment of the taxonomic units previously recommended 
for the QPS list (EFSA BIOHAZ Panel, 2013) will be carried out less frequently (every three years) 
through a scientific opinion of the BIOHAZ Panel. In any case, the recommendations provided 
concerning that list of microorganisms will be maintained and frequently checked based on the 
evaluation of extensive literature reviews which will be updated regularly with new publications. 
Intermediate deliverables in the form of a Panel statement will be produced and published, should an 
assessment for a QPS classification of a microbiological agent notified to EFSA be requested by Feed, 
Food Ingredients and Packaging (FIP), Nutrition or Pesticides Units. Evaluations of these notifications 
will be compiled in a single statement for periods of around six months. The results of these 
assessments will also be included in the scientific opinion to be published in December of 2016. The 
“2013 updated list of QPS status recommended biological agents for safety risk assessments carried 
out by EFSA Scientific Panels and Units”, will be appended to each Panel statement. New biological 
agents recommended for the QPS status will be included in that list, after the assessment of the new 
notifications by the BIOHAZ Panel.  
2. Methodology 
In response to ToR1, the EFSA Units (Feed, FIP, Nutrition and Pesticides Units), have been asked to 
update the list of biological agents being notified to EFSA. For the current statement, 99 notifications 
were received between May 2013 and October 2014, of which, 47 from Feed, 44 from FIP, 3 from 
Nutrition and 5 from Pesticides.  
                                                     
8  Commission Implementing Regulation (EU) No 562/2012 of 27 June 2012 amending Commission Regulation (EU) No 
234/2011 with regard to specific data required for risk assessment of food enzymes. OJ L 168, 28.6.2012, p. 21-23. 
9  Commission Regulation (EU) No 234/2011 of 10 March 2011 implementing Regulation (EC) No 1331/2008 of the 
European Parliament and of the Council establishing a common authorisation procedure for food additives, food enzymes 
and food flavourings. OJ L 64, 11.3.2011, p. 15-24. 
10  Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a 
common authorisation procedure for food additives, food enzymes and food flavourings. OJ L354, 31.12.2008, p. 1-6. 
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In response to ToR3, from those 99 notifications, 26 biological agents already had a QPS status and 
were not further evaluated neither the 54 biological agents that are filamentous fungi or enterococci, 
biological groups which have been excluded from QPS activities (in the follow up of a 
recommendation of the QPS 2013 update (EFSA BIOHAZ Panel, 2013)). The remaining 19 biological 
agents were assessed for the suitability of the respective taxonomic units for inclusion in the QPS list. 
From the assessed taxonomic units, 16 species were notified to the Feed Unit, 2 to the FIP Unit and 
one to the Nutrition Unit. The respective taxonomic units (total of 13) were assessed for their 
suitability to the QPS list. Of a total of 12 bacterial taxonomical units evaluated, 10 were notified to 
the Feed Unit (Actinomadura roseorufa, Bacillus toyonensis (previously B. cereus var. toyoi), 
Carnobacterium divergens, Clostridium butyricum, Escherichia coli, Paenibacillus lentus, 
Streptomyces albus, Streptomyces aureofaciens, Streptomyces lasaliensis, Streptomyces 
cinnamonensis), one to the FIP Unit (Microbacterium imperiale) and one by the Nutrition Unit 
(Bacteroides xylanisolvens). The only yeast taxonomic unit evaluated was notified to the FIP Unit 
(Candida cylindracea). 
The procedure followed for this assessment is the same as in the previous QPS 2013 update of the 
scientific opinion.  
Table 1:  Notifications received by EFSA Units (Feed, FIP, Nutrition and Pesticides Units) and by 
biological group from May 2013 until October 2014 
Unit/ Panel  Not QPS Already QPS Grand Total 
Biological group  Not evaluated Evaluated 
Feed/FEEDAP  16 16 15 47 
Bacteria  1 16 9 26 
Filamentous fungi  15   15 
Yeasts    6 6 
FIP/CEF  34 2 8 44 
Bacteria   1 6 7 
Filamentous fungi  34  1 35 
Yeasts   1 1 2 
Nutrition/NDA   1 2 3 
Bacteria   1 1 2 
Yeasts    1 1 
Pesticides/PPR  4  1 5 
Filamentous fungi  4   4 
Viruses    1 1 
Grand Total  54 19 26 99 
 
For the taxonomic units associated with the notifications compiled within the time period covered by 
this statement (from May 2013 until October 2014), the literature review was broader in order to 
consider the identity, the body of knowledge, history of use and the potential safety concerns. 
Relevant databases such as PubMed, Web of Knowledge, CasesDatabase, GoogleScholar, CAB 
Abstracts or Food Science Technology Abstracts (FSTA) were searched using specific sections. 
Keywords used may equally be specified in the specific section. Some common keywords such as the 
taxonomic unit in combination with ‘toxin’, ‘disease’, ‘infection’, ‘clinical’, ‘virulence’, 
‘antimicrobial and/or antibiotic/antimycotic resistance’, ‘safety’, ‘risk’, ‘abortion’, ‘urinary’, 
‘mastitis’, ‘syndrome’, ‘vaginitis’. In addition some animal categories such as ‘poultry’, ‘chicken’, 
‘hen’, ‘broiler’, ‘turkey’, ‘fowl’, ‘piglet’, ‘pig’, ‘calf’, ‘calves’, ‘cattle’, ‘cow’, ‘fish’ and ‘salmon’ 
were generally applied. Relevant studies were evaluated, reported and discussed. The search terms 
were broad and covered synonyms or former names of taxonomic units. 
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3. Bacteria  
3.1. Actinomadura roseorufa 
Identity 
The genus Actinomadura consists of Gram-positive actinobacteria belonging to the order 
Actinomycetales, (fam. Thermomonosporaceae) and is composed of microorganisms with cell walls 
containing meso-2,6-diaminopimelic acid and madurose but lacking arabinose and galactose. 
Actinomadurae are chemo-organotrophs that produce stable vegetative mycelia and aerial hyphae 
differentiating into spore chains. The genus currently contains 37 species including 2 subspecies 
(Euzéby and Tindall, online) and they are known to produce bioactive secondary metabolites. The 
taxonomy identification of this bacterium is not established as a species with a validated name in 
IJSEM and LPSN.
11
 
Actinomadura roseorufa is notified as a producer of semduramicin, a polyether ionophor (Microbial 
Genomes, online), to be used as a feed supplement acting as a coccidiostat to inhibit intestinal coccidia 
(Rutkowski and Brzezinski, 2013). No strain belonging to this species has been fully sequenced 
according to NCBI (Microbial Genomes, online).   
Body of knowledge 
No scientific reports or articles on the safety of A. roseorufa have been found. A search in the 
Thomson Reuters Web of Science (1 October 2014) using “Actinomadura roseorufa” as search term in 
“topic” retrieved 9 hits all related to the production and properties of semduramicin. The body of 
knowledge is limited to the use of strains as producers of this compound. Since A. roseorufa produces 
semduramicin, its use in feed might promote bacterial resistance.  
The safety of  semduramicin when used as coccidiostat for fattening of chickens has been assessed by 
EFSA (EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), 2011). 
The general conclusion from this report is that on the basis of the data provided on semduramicin 
sodium for use as feed additive under the proposed conditions of use, the safety of semduramicin is 
demonstrated for the target animal, the user, the consumer and the environment. Consequently, an 
additive containing semduramicin has been authorized as cocciodiostat in the EU (EFSA Panel on 
Additives and Products or Substances used in Animal Feed (FEEDAP), 2011). 
Safety concerns 
A. roseorufa produces semduramicin, an approved coccidiostat, with antimicrobial activity. The 
possible contribution of this ionophore to the development of antibiotic resistance to important human 
antibiotics is a matter of concern. No studies on the safety of A. roseorufa were found. Therefore no 
definitive conclusions can be attained. There is a limited number of reports from EFSA on the safety 
concerns of semduramicin (EFSA Panel on Additives and Products or Substances used in Animal Feed 
(FEEDAP), 2011). 
Conclusions on a recommendation for the QPS list 
A. roseorufa produces semduramicin, an approved coccidiostat, with antimicrobial activity and 
therefore cannot be considered for the QPS list. Moreover its identity is not well established. 
3.2. Bacillus toyonensis (previously B. cereus var. toyoi) 
Identity  
The species Bacillus toyonensis was recently published in the validation list no 155 (Oren and Garrity, 
2014).  
                                                     
11
 http://www.bacterio.net/ 
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The phylogenetic analysis of the 16S rRNA, 23S rRNA and of the gyrB gene sequences and average 
nucleotide identity calculations, derived from the whole genome sequence indicate that the species 
B. toyonensis belongs to the B. cereus group or B. cereus sensu lato (Jimenez et al., 2013).  
Body of knowledge  
B. toyonensis was originally called B. cereus var. toyoi, and was represented by a single strain 
authorized in the past in the EU as a feed additive for various farm animal species (EFSA, 2004, 2005, 
2007a, b; Williams et al., 2009). The body of knowledge concerns therefore, only one strain and not a 
generic taxonomic unit. Similarly, a publication (Jimenez et al., 2013) describes B. toyonensis on the 
basis of one strain.  
Safety concerns 
B. toyonensis was included before 2013 within the species B. cereus (EFSA, 2004, 2005, 2007a, 
2007b; Williams et al., 2009). Therefore, the safety concerns defined for B. cereus, which led to the 
conclusion in 2007 (EFSA, 2007c) that B. cereus and related species (such as B. thuringiensis) should 
not be included in the QPS list, apply to B. toyonensis, unless specific information could relieve these 
concerns. Jimenez et al. (2013) do not provide any specific information for B. toyonensis with regards 
to the toxins known to be produced by the B. cereus group. The safety of the only described 
B. toyonensis strain intended to be used as a feed additive has recently been reassessed by EFSA 
(EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), 2012; EFSA 
FEEDAP Panel, 2014). These assessments concluded that this strain has the capacity to produce 
functional B. cereus toxins. All the above information concerns a single strain, and cannot be extended 
to the B. toyonensis species, should more strains of the species were described.  
Conclusions on a recommendation for the QPS list 
In conclusion, Bacillus toyonensis cannot be proposed for the QPS list because it is a member of the 
B. cereus group, and because of the absence of evidences at the species level that it does not present 
safety concerns.  
3.3. Bacteroides xylanisolvens  
Identity 
The first report on Bacteroides xylanisolvens (Chassard et al., 2008) described the new species mainly 
based on 16S rRNA sequence and carbohydrate metabolism differences to other Bacteroides. The type 
strain was also designated. Presently, there are five strains that received attention, all of which were 
defined by their 16S rRNA sequences. One strain was isolated from human feces (Ulsemer et al., 
2012a), two based on their capacity to ferment xylan (Chassard et al., 2008; Mirande et al., 2010) and 
the other two after growing on cellulose (Ramaraj et al., 2014). Draft genome sequences have been 
deposited for these last two and the type strain.  
Body of knowledge 
The body of knowledge of the species in mainly based on its ability to ferment carbohydrates 
(Chassard et al., 2008; Mirande et al., 2010; Ramaraj et al., 2014). No record of its use in food 
fermentation processes exists, and only a couple of pilot studies using fermented milk were performed 
(Ulsemer et al., 2012b). Therefore the body of knowledge on use of B. xylanisolvens as a food or feed 
ingredient is limited. 
Safety concerns 
Tests on the safety of B. xylanisolvens have been mainly performed in vitro (Mirande et al., 2010; 
Ulsemer et al., 2012a, c) although some studies on mice, mainly intraperitoneal injection of live 
bacteria, indicate that the pathogenic potential of the strain used may be low (Ulsemer et al., 2012c). 
Finally, two complementary pilot studies with healthy volunteers that received orally administered 
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dead bacteria have not shown changes in several immunological parameters and liver markers 
(Ulsemer et al., 2012b). 
Although no safety concerns have been observed, the studies published are insufficient to exclude 
safety concerns. The human cohorts used in the pilot studies were small and used killed bacteria on 
healthy volunteers. This is a limitation to the use of strains of this species as probiotics, which, by 
definition, have to be alive.  
Conclusions on a recommendation for the QPS list 
Bacteroides xylanisolvens is not recommended for the QPS list, because the body of knowledge is 
insufficient and safety concerns cannot be totally excluded. 
3.4. Carnobacterium divergens 
Identity 
The Carnobacterium genus belongs to the family Carnobacteriaceae in the order of Lactobacillales 
(Collins et al., 1987). The most important species is Carnobacterium maltaromaticum due to its 
common occurrence in foods of animal origin. Carnobacterium divergens (and later also 
C. maltaromaticum) has been reclassified and transferred from the genus Lactobacillus to the 
described genus nov. Carnobacterium in 1987 (Collins et al., 1987) based on phenotypic 
classification. The first description was given by Holzapfel and Gerber (1983). The original strains 
were isolated from raw vacuum-packaged, as well as SO2-treated, minced beef, in the course of shelf 
life studies on this product (Holzapfel and Gerber, 1983). The complete genome sequence is known 
for some strains of Carnobacterium spp., but not for C. divergens. 
Body of knowledge 
The species C. divergens frequently dominates the microbiota of refrigerated meat and seafood, stored 
under vacuum or modified atmosphere (Laursen et al., 2005; Leisner et al., 2007; Rieder et al., 2012). 
For its ability to produce bacteriocins, this species has been used in food with the aim to reduce 
spoilage and pathogenic bacteria (Richard et al., 2003; Leisner et al., 2007; Rihakova et al., 2009). 
C. divergens has been also studied as probiotic for fish, such as Atlantic cod (Gadus morhua L.) 
(Lauzon et al., 2010), Atlantic salmon (Salmo salar L.) (Ringø et al., 2007) and rainbow trout 
(Oncorhynchus mykiss) (Kim and Austin, 2008), and as probiotic for chicken for fattening (Jozefiak et 
al., 2011). 
Safety concerns 
In a single study two strains of C. divergens, isolated from the blood of a newborn delivered by 
caesarean section and from a febrile lymphoma patient, were identified by sequencing the variable 
regions of the 16S rRNA gene. The two strains encode a possibly acquired new class A β-lactamase 
(Meziane-Cherif et al., 2008). Strains carrying these determinants for resistance can be detected 
following the Euzéby and Tindall (online) applying the ampicillin cut off value defined for 
“Lactobacillus heterofermentatives”.  
However, these infections represent extremely rare individual cases, occurring on highly vulnerable 
individuals, so that these microorganisms cannot be considered as pathogenic taking into account the 
extent of exposure. 
Conclusions on a recommendation for the QPS list 
The taxonomic unit is well described and the body of knowledge shows it as a common species in the 
food chain, especially in meat. Carnobacterium divergens can be recommended for the QPS list with 
the qualification of absence of acquired antibiotic resistance determinants.  
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3.5. Clostridium butyricum 
Identity 
Clostridium butyricum is a well described species and it is the type species of the genus (Collins et al., 
1994). 
Body of knowledge 
C. butyricum was assessed as non-suitable for QPS in 2011 because some strains can produce 
botulinum toxin E (EFSA Panel on Biological Hazards (BIOHAZ), 2011).  
Regarding the history of use, several reports on the use of C. butyricum as probiotic in animals and 
humans, were found (Yang et al. (2012); Zhang et al. (2014) on broilers; Uyeno et al. (2013) on 
calves; Imase et al. (2008); Sharma et al. (2008); Chen et al. (2010); Sato et al. (2012) on human 
subjects). UK the “Advisory Committee on Novel Foods and Processes” issued a draft opinion in 2013 
on C. butyricum CBM588  as a novel ingredient to be added to supplements and concluded that “it did 
not have any unanswered safety concerns relating to this novel ingredient” (ACNFP, online). These 
studies concern a limited number of strains, in particular several used the same strain C. butyricum 
CBM588.  
Safety concerns 
A minority of strains of C. butyricum are able to form botulinum neurotoxin type E, harbouring 
BoNT/E gene on a large plasmid (Hauser et al., 1992; Peck, 2009; Ghoddusi and Sherburn, 2010). 
Toxigenic strains of this species were responsible for infant botulism (Fenicia et al., 1999; Abe et al., 
2008) and involved in foodborne intoxications. Botulinum neurotoxins are extremely potent toxins. 
Methods exists to detect the genes coding for these toxins and to detect the production of the toxins by 
the bacteria.  
New safety concerns are indicated by one report of bacteremia in a drug addict who very likely 
injected himself drug contaminated with C. butyricum (Gardner et al., 2008). C. butyricum was also 
suspected to be one of the bacterial species contributing to necrotizing enterocolitis in premature 
infants (Waligora-Dupriet et al., 2009; Morowitz et al., 2010). Therefore, C. butyricum has been a rare 
cause of human disease in association with very specific risk factors.  
Conclusions on a recommendation for the QPS list 
The information collected supports the view that the safety of C. butyricum is only known for a few 
strains, therefore Clostridium butyricum is not recommended for the QPS list. Thus, no additional 
information supports a revision of the previous conclusion attained in 2011. 
3.6. Escherichia coli  
Escherichia coli was assessed in 2009 as not suitable for the QPS list with the following conclusion: 
"although some E. coli (e.g. E.coli Nissle 1917 (EcN)) have a long history of safe use as probiotics, 
and in spite of the large body of knowledge acquired for this species, it cannot be recommended for 
the QPS list because of the large diversity of human and animal diseases caused by E. coli and the 
complexity of the virulence mechanisms (DSMZ, online)". 
Identity 
E. coli are Gram-negative, facultative anaerobic bacteria, belonging to the family Enterobacteriaceae, 
which are taxonomically placed within the gamma subdivision of the Proteobacteria phylum. 
E. coli isolates have been divided into subgroups attending to various criteria, either related to 
pathogenicity towards the human host, serology (e.g. serotypes O127:H7 or K1) or, mainly for 
population genetic purposes, phylogenetic properties of particular housekeeping genes (subdivided in 
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seven major phylogenetic groups A, B1, B2, C, D, E and F) (Jaureguy et al., 2008).The E. coli core 
genome corresponds to less than half the pangenome, with most of the E. coli genes in any given 
genome being found in some strains, but missing in others (Fukiya et al., 2004; Lukjancenko et al., 
2010). 
Body of knowledge 
E. coli is a versatile bacterium, both retrieved in the environment or as a commensal of the intestinal 
tract of humans and animals. Beside these habitats, certain strains have the potential to cause a wide 
spectrum of intestinal and extra-intestinal diseases such as urinary tract infection, septicaemia, 
meningitis, and pneumonia in humans and animals.  
E. coli, the most extensively studied prokaryote, was brought into laboratories almost a century ago to 
become one of the most important model organisms. Some of these laboratory E. coli strains, (e.g. 
E. coli K-12) have been used as host organisms, namely for producing aminoacids for use in animal 
feed (Bachmann, 1972). 
Safety concerns 
The ability of an E. coli strain to behave as a commensal or an extra-intestinal pathogen is determined 
by a complex balance between many factors, e.g. immune status of the host, production of virulence 
factors by the bacterium, portal of entry, inoculum dose, and the genetic background of the bacterium. 
Several virulence determinants are recognized, either involved in enteric infection (e.g. enterotoxins 
and pili) and/or in extra-intestinal infections (e.g. siderophores, mucinase, cytotoxins, 
immunomodulators, lectin-like hemagglutinin and colibactin) (Pacheco and Sperandio, 2012; Ruiz-
Perez and Nataro, 2014). Recently, worrying observations about their potential implication in colon 
cancer were described, although apparently associated to a specific phylogenetic group (Nowrouzian 
and Oswald, 2012). Moreover, an incomplete understanding of the virulence factors triggering all 
clinical disease presentations, including for neonatal meningitis-causing E. coli, still persist 
(Wijetunge et al., 2014). These facts prevent the proposal of a set of precise qualifications for QPS 
status. 
Conclusions on a recommendation for the QPS list 
Escherichia coli cannot be proposed for the QPS list as the safety evaluation has to be done on strain 
level. No further knowledge supports a revision of the previous conclusion attained in 2009. 
3.7. Microbacterium imperiale  
Identity 
Microbacterium imperiale, previously known as Brevibacterium imperiale, was included in the genus 
based on its close relationship to Microbacterium lacticum (Collins et al., 1983). The genus is 
phylogenetically coherent as determined by 16S rRNA gene sequencing and chemotaxonomic data 
(Takeuchi and Yokota, 1994; Rivas et al., 2004; Park et al., 2006; 2008). The bacteria of the genus 
Microbacterium are Gram positive organisms that belong to the Phylum Actinobacteria 
(G + C ≈ 66-70 %), strictly aerobic, rod shaped and usually non-motile.  
Body of knowledge 
Their habitat is the soil where they thrive on plant decaying material thanks to their enzymatic 
potential to degrade complex polysaccharides. Xylanolytic, amilolytic and β-glucosidase activities 
have been detected in different isolates of the genus (Rivas et al., 2004; Park et al., 2006; 2008; Wu et 
al., 2014). Endophytic and gut of caterpillar associated strains have been isolated as well (Zinniel et 
al., 2002; Huang et al., 2012; Gan et al., 2014), with no signs of pathology perceived in the colonized 
plant or animal tissues. 
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No records of intended use of M. imperiale cells in foods manufacturing exist. However, the enzymes 
produced by organisms of the genus are used in food processing. Of special interest to this evaluation 
is the use of the 1,4-α-maltotriohydrolase for the production of maltotriose, an oligosaccharide used 
for the production of desserts and baked pastries (Anonymous, 2000, 2011; Wu et al., 2014) . 
Safety concerns 
In literature, no association of M. imperiale to pathology has been reported. In fact, out of the 
84 species of the genus Microbacterium only four have been described as involved in human 
pathological processes, the cases being extremely rare, occurring in patients with predisposing 
conditions and, in some cases, being part of a polymicrobial infection (Alonso-Echanove et al., 2001; 
Giammanco et al., 2006; Adames et al., 2010; Enoch et al., 2011; Buss et al., 2014). The frequent need 
of a previous life-threatening or immunodeficiency condition for successful Microbacterium spp. 
infection may indicate that no significant virulence factors are produced by the species of this genus. 
Finally, resistance to chemotherapy appears to be scarce, with an almost universal susceptibility to β-
lactam and glycopeptide antibiotics (Adames et al., 2010; Buss et al., 2014). 
 
Conclusions on a recommendation for the QPS list 
No record exists of intended use of any Microbacterium in food processing and/or ingestion of viable 
cells. However, there is a history of use in food processing of enzymes produced by Microbacterium 
imperiale, therefore it can only be recommended for QPS for enzyme production. 
3.8. Paenibacillus lentus  
Identity 
Paenibacillus lentus was described recently as a new species by Li et al. (2014), as a β-mannanolytic 
bacterium isolated from soil.  
Body of knowledge 
No information was found on P. lentus apart from its description as a new species.  
Safety concerns 
No experimental information has yet been developed and/or available. 
Conclusions on a recommendation for the QPS list 
Due to the absence of a body of knowledge apart from the description of the species, Paenibacillus 
lentus cannot be proposed for the QPS list.  
3.9. Streptomyces albus   
Identity 
Streptomyces albus is the type species of the genus Streptomyces and appears to be a coherent 
taxonomic entity, as judged by 16S rRNA gene sequence and multilocus sequence analysis (Labeda et 
al., 2014). The only strain that has been completely sequenced is S. albus J1074 (Olano et al., 2014; 
Zaburannyi et al., 2014). This strain does not carry the gene cluster encoding for salinomycin 
biosynthesis, thus suggesting a high intraspecies variability.   
Body of knowledge 
There is a long record of use of salinomycin as an anticoccidial additive, especially with chicken 
(Yvoré et al., 1980; Lee et al., 2013). However, cases of accidental salinomycin intoxication to 
turkeys, horses, calves and other farm animals that involve internal organ compromise (cardiac and 
muscular lesions) and even death have been reported (Potter et al., 1986; Aleman et al., 2007; 
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Holliman et al., 2011). It is not clear in these cases whether salinomycin is being administered as a 
pure compound or as a crude extract.  
The bacteria of this species are virtually avirulent, although a report exists in which an 
actinomycetoma developed in the forearm of a person that had previously been treated with 
corticosteroids. The identity of the infection was determined through 16S rRNA gene sequencing 
(Martin et al., 2004).  
Safety concerns 
Apart from the toxicity referred to in the previous paragraph, there are two other reasons for concern: 
 Salinomycin is demonstrating a potential as an anticancer agent, especially for stem cell and 
prostate tumors (Zhou et al., 2013). Its use in feed might promote resistance development as a 
consequence of its ingestion with the meat of treated animals. 
 The sequenced strain S. albus J1074, in spite of not harbouring the cluster for salinomycin 
production, has the potential to synthesize 27 secondary metabolites, the majority of which 
have antimicrobial properties (Olano et al., 2014; Zaburannyi et al., 2014). The capacity to 
produce multiple antimicrobials is general among the streptomycetes that have been 
completely sequenced and it can be assumed that this can be the case also for the salinomycin 
producer. The potential production of this kind of compounds by S. albus represents a risk of 
toxicity and generation of resistance in the intestinal microbiota that might become 
subsequently transferred to pathogens. 
S. albus appears to be a complex species that includes strains harbouring different sets of gene clusters 
that encode a wide variety of metabolites with biological activity. This means that the lack of toxicity 
and of antibiotic activity has to be tested on a strain basis.  
Conclusions on a recommendation for the QPS list 
Streptomyces albus is not recommended for the QPS list, because safety concerns cannot be excluded. 
3.10. Streptomyces aureofaciens  
Identity 
Streptomyces aureofaciens was initially described in 1948 as a narasin producer although, depending 
on the strain, it also produces tetracyclines and other biologically active compounds. Its taxonomy was 
settled on the basis of extensive phenotypic properties (Groth et al., 2003).   
However, no strain belonging to the species has been fully sequenced according to NCBI (Microbial 
Genomes, online).   
Body of knowledge 
There is a long record of using narasin as an anticoccidial additive (Peeters et al., 1981; Jeffers et al., 
1988; Brennan et al., 2001) although the extent of usage is not comparable to that of other polyether 
ionophores such as salinomycin and monensin. Accidental narasin intoxication of rabbits and of some 
laboratory animal species may involve diarrhea and internal organ compromise, including respiratory 
stress, skeletal muscle degeneration and even death (Novilla et al., 1994; Salles et al., 1994; Oehme 
and Pickrell, 1999). This toxicity appears to be, however, less pronounced than that of salinomycin 
and monensin (Dorne et al., 2013). There are no clinical reports involving S. aureofaciens in human 
disease. 
Safety concerns 
Apart from the toxicity referred to in the previous paragraph, there are two other reasons for concern: 
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 Narasin belongs to the same family as that of salinomycin and monensin. These two drugs are 
being tested as possible anticancer agents (Zhou et al., 2013; Tumova et al., 2014). The 
possibility exists that use of narasin as an additive in feed might promote cross-resistance 
development as a consequence of its ingestion with the meat of treated animals. 
 The biosynthetic capacity of S. aureofaciens cannot be assessed due to lack of information on 
its genome. However, the common occurrence of multiple pathways encoding secondary 
metabolites among the streptomycetes whose genomes are known, allow hypothesizing that 
this might also be the case for this QPS candidate. Many of these secondary metabolites act as 
antimicrobials. The potential production of this kind of compounds by S. aureofaciens 
represents a risk of toxicity and generation of resistance in the intestinal microbiota that might 
become subsequently transferred to pathogens.  
Knowledge of the strain and, by extension, of the species it belongs to, is not enough to ensure a safe 
application. Especially important is the fact that the ability to produce secondary metabolites appears 
to be strain-specific. Finally, narasin seems to have moderate toxicity to man and animals. Under these 
circumstances, toxicity and co-production of antibiotics has to be excluded on a strain basis.  
Conclusions on a recommendation for the QPS list 
Streptomyces aureofaciens is not recommended for the QPS list, because the body of knowledge is 
limited and safety concerns cannot be excluded. 
3.11. Streptomyces cinnamonensis  
Identity 
A search in Pub-Med using the key word Streptomyces cinnamonensis, retrieved 69 articles, the vast 
majority of which dealt with different aspects of monensin production. No paper on S. cinnamonensis 
taxonomic characteristics was found, apart from some that justified classification of S. cinnamonensis 
16S rRNA-related strains into new species. Furthermore, no strain belonging to the species has been 
fully sequenced according to NCBI (Microbial Genomes, online).  All this indicates absence of 
coherence of the taxonomic unit.   
Body of knowledge 
There is a long record of using monensin as an anticoccidial additive (McDougald, 1976; Chapman et 
al., 2010; Pirali Kheirabadi et al., 2014). However, cases of accidental monensin intoxication of 
chicken, horses and other farm animals that may involve internal organ compromise, including 
myocardial and neurological damage and even death have been reported (Matsuoka, 1976; Oehme and 
Pickrell, 1999; Zavala et al., 2011). There are no clinical reports involving S. cinnamonensis in human 
disease.  
Safety concerns 
Apart from the toxicity referred to in the previous paragraph, there are two other reasons for concern: 
 Monensin is being tested as a possible anticancer agent, although the studies are not as 
advanced as with salinomycin, another polyether ionophore with a similar mode of 
antimicrobial action (Choi et al., 2013; Tumova et al., 2014). Its use in feed might promote 
resistance development as a consequence of its ingestion with the meat of treated animals. 
 The biosynthetic capacity of S. cinnamonensis cannot be assessed due to lack of information 
on its genome. However, the common occurrence of multiple pathways encoding secondary 
metabolites among the streptomycetes whose genomes are known indicates that this might 
also be the case for this QPS candidate. Many of these secondary metabolites act as 
antimicrobials. The potential production of this kind of compounds by S. cinnamonensis 
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represents a risk of toxicity and generation of resistance in the intestinal microbiota that might 
become subsequently transferred to pathogens. 
Knowledge of the strain and, by extension, of the species it belongs to, is not enough to ensure a safe 
application. Especially important is the fact that the ability to produce secondary metabolites appears 
to be strain-specific. Finally, monensin seems to have moderate toxicity to man and animals. Under 
these circumstances, toxicity and co-production of antibiotics has to be excluded on a strain basis.  
Conclusions on a recommendation for the QPS list 
Streptomyces cinnamonensis is not recommended for the QPS list, because the body of knowledge is 
limited and safety concerns cannot be excluded. 
3.12. Streptomyces lasaliensis  
Identity 
The majority of the 13 articles retrieved with the use of the Streptomyces lasaliensis key words were 
devoted to the study of the lasalocid genetic cluster and to the production of terpenoids. No paper on 
the taxonomy of the species was retrieved. Its identity may be more dependent on production of 
lasalocid than on biological characteristics in general. Moreover, no strain belonging to the species has 
been fully sequenced according to Microbial Genomes (online).   
Body of knowledge 
There is a long record of using lasalocid as an anticoccidial additive, with some emphasis on the 
treatment of calves (Reid et al., 1975; Stromberg et al., 1982; Fuller et al., 2008) although the extent of 
usage is not comparable to that of other polyether ionophores. Intoxication of cattle and horses with 
lasalocid may result in myocardial and neurological damage and even death (Galitzer et al., 1986; 
Oehme and Pickrell, 1999; Decloedt et al., 2012). This toxicity appears to be, however, less 
pronounced than that of salinomycin and monensin (Dorne et al., 2013). There are no clinical reports 
involving S. lasaliensis in human disease.  
Safety concerns 
Apart from the toxicity referred to in the previous paragraph, there are two other reasons for concern: 
 Lasalocid belongs to the same family of compounds as salinomycin and monensin. These two 
drugs are being tested as possible anticancer agents (Zhou et al., 2013; Tumova et al., 2014). 
The possibility exists that the use of lasalocid in feed might promote cross-resistance 
development as a consequence of its ingestion with the meat of treated animals. 
 The biosynthetic capacity of S. lasaliensis cannot be assessed due to lack of information on its 
genome. However, the common occurrence of multiple pathways encoding secondary 
metabolites among the streptomycetes whose genomes are known, allow hypothesizing that 
this might also be the case for this QPS candidate. Many of these secondary metabolites act as 
antimicrobials. The potential production of this kind of compounds by S. lasaliensis represents 
a risk of toxicity and generation of resistance in the intestinal microbiota that might become 
subsequently transferred to pathogens. 
Knowledge of the strain and, by extension, of the species it belongs to, is not enough to ensure a safe 
application. Especially important is the fact that the ability to produce secondary metabolites appears 
to be strain-specific. Finally, lasalocid seems to have moderate toxicity to man and animals. Under 
these circumstances, toxicity and co-production of antibiotics has to be excluded on a strain basis.  
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Conclusions on a recommendation for the QPS list 
Streptomyces lasaliensis is not recommended for the QPS list, because its identity is not well 
established, the body of knowledge is limited and safety concerns cannot be excluded. 
3.13. General conclusion for the genus Streptomyces on a recommendation for the QPS list 
Streptomycetes are essentially non-virulent, with the exception of some plant pathogens such a 
S. scabies. However, they produce antibiotics and may thus select for resistant bacteria. Other 
secondary metabolites have diverse biological activities that go from depressors of the immune system 
to herbicides (Butaye et al., 2003). Genome sequencing has revealed that streptomycetes carry several 
gene clusters for the production of secondary metabolites, many of which may be toxic, or select for 
antimicrobial resistance. Furthermore, the presence of specific clusters varies on a strain basis. All this 
precludes the consideration of any species of the genus as a QPS organism. 
4. Yeast 
4.1. Candida cylindracea  
Identity 
C. cylindracea belongs to the Ogataea clade of the Ascomycetous yeasts (Kurtzman et al., 2011; 
Daniel et al., 2014). The species was described by Yamada and Machida (1962), and validated by 
Meyer and Yarrow (1998). No synonym names have been used. Only the anamorphic form is known 
and described. The type strain for C. cylindracea – CBS 6330 – is also marketed under other 
designations, e.g.  DSMZ 2031 (online) and ATCC 14930 (online). Unfortunately, in the literature on 
lipase-producing yeasts, the C. cylindracea type strain has at times been referred to as Candida rugosa 
(e.g. Benjamin and Pandey (1998); Takaç et al. (2010)). This has caused some confusion since 
C. cylindracea and C. rugosa are two well defined species, not closely related phylogenetically 
(Kurtzman et al., 2011). It is also unfortunate since C. rugosa is considered an emerging, opportunistic 
yeast (Miceli et al., 2011). However, identification according to molecular methods can easily separate 
between the two species. It is therefore recommended that the species identity of lipase-producing 
strains of Candida is confirmed by using such methods. 
Body of knowledge 
C. cylindracea has been used for a long time in industry as a lipase producer (Tomizuka et al., 1966; 
Brozzoli et al., 2009). The Ogataea clade to which it belongs does not include the pathogenic yeast 
Candida albicans (which belongs to the Lodderomyces-Spathaspora clade) or other Candida species 
associated with human infections, like C. tropicalis, C. glabrata, C. parasilopsis or C. rugosa. 
Safety concerns 
A literature search for “Candida cylindracea” on Thomson Reuters Web of Science (7 July 2014) 
gave 797 hits. The vast majority of the retrieved studies treated different aspects of enzyme production 
by this species. None of the studies implied a potential safety issue for C. cylindracea. No clinical 
reports for C. cylindracea were recovered in the search and the species is not mentioned in reviews on 
emerging opportunistic yeasts (e.g. Miceli et al. (2011)). C. cylindracea does not grow at 37 °C 
(Kurtzman et al., 2011).  
Conclusions on a recommendation for the QPS list 
In the Candida cylindracea bibliography, the species was only reported for use as an enzyme producer 
and no safety concerns were identified. Therefore it was concluded that it can be recommended for 
QPS status. However, since there were no reports on its use in applications involving direct 
consumption of Candida cylindracea viable cells by humans or animals, QPS should apply only for 
the production of enzymes.  
BIOHAZ statement on QPS: suitability of taxonomic units notified to October 2014 
 
EFSA Journal 2014;12(12):3938 19 
CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
ToR 1: Keep updated the list of biological agents being notified, in the context of a technical dossier to 
EFSA Units (such as Feed, Food Ingredients and Packaging (FIP), Nutrition and Pesticides), for 
intentional use in feed and/or food or as sources of food and feed additives, enzymes and plant 
protection products for safety assessment:  
 Between May 2013 and October 2014, 99 notifications were received from those four Units, of 
which 44 from FIP, 47 from Feed, 3 from Nutrition and 5 from Pesticides.  
ToR 2: Review taxonomic units previously recommended for the QPS list and their qualifications 
(especially the qualification regarding antimicrobial resistance) when new information has become 
available:  
 The work being developed in order to reply to this ToR is not reflected in the current Panel 
statement. 
 This ToR is being dealt with by the QPS working group and the ongoing revision of the overall 
assessment of the biological agents included in the 2013 QPS update opinion will be published 
through a scientific opinion of the BIOHAZ Panel in December of 2016.  
ToR 3: (Re)assess the suitability of taxonomic units notified to EFSA not present in the current QPS 
list for their inclusion in that list: 
 Of those 99 notifications received, 26 biological agents already had a QPS status and were not 
further evaluated.  
 From the remaining 73 (without a QPS status), 54 biological agents were not further assessed as 
they are filamentous fungi or enterococci, biological groups which have been excluded from QPS 
activities, and 19 were further assessed for the suitability of the respective taxonomic units for 
inclusion in the QPS list.  
 From the assessed taxonomic units, 16 species were notified to the Feed Unit, 2 to the FIP Unit 
and one to the Nutrition Unit. The respective taxonomic units (total of 13) were assessed for their 
suitability to the QPS list.  
 Of a total of 12 bacterial taxonomical units evaluated, 10 were notified to the Feed Unit 
(Actinomadura roseorufa, Bacillus toyonensis (previously B. cereus var. toyoi), Carnobacterium 
divergens, Clostridium butyricum, Escherichia coli, Paenibacillus lentus, Streptomyces albus, 
Streptomyces aureofaciens, Streptomyces lasaliensis, Streptomyces cinnamonensis), one to the FIP 
Unit (Microbacterium imperiale) and one to the Nutrition Unit (Bacteroides xylanisolvens). The 
only yeast taxonomic unit evaluated was notified to the FIP Unit (Candida cylindracea). 
 For 3 of the 13 taxonomic units assessed, no safety concerns were found than a specific 
qualification or an indication for a specific use (food enzyme production), therefore a 
recommendation for a QPS status was included and the 2013 updated QPS list.  
RECOMMENDATIONS 
Three taxonomic units were recommended for the QPS list: 
a) Carnobacterium divergens with the qualification of absence of acquired antibiotic resistance 
determinants; 
b) Microbacterium imperiale only for enzyme production;  
c) Candida cylindracea only for enzyme production. 
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APPENDICES 
Appendix A.  The 2013 updated list of QPS Status recommended biological agents in support 
of EFSA risk assessments – 1st revision (new additions) 
The 2013 update list of QPS Status recommended biological agents for safety risk assessments carried 
out by EFSA Scientific Panels and Units, as shown in Table 1 below, is undergoing a revision process 
in accordance with a self-task mandate of the BIOHAZ Panel. The revisions will be published as an 
Appendix to a Statement of the BIOHAZ Panel around every six months, with the first revision in 
December 2014 and the last revision as an Appendix to a Scientific Opinion of the BIOHAZ Panel in 
December 2016. The most up-to-date QPS list will be published on the web as an Appendix of the 
corresponding revision and also as a separate file associated with the respective revision. 
Table 1:   The 2013 updated list of QPS Status recommended biological agents for safety risk 
assessments carried out by EFSA Scientific Panels and Units – 1st revision (new additions) 
Gram-Positive Non-Sporulating Bacteria 
Species  Qualifications *   
Bifidobacterium 
adolescentis  
Bifidobacterium animalis 
Bifidobacterium bifidum  
Bifidobacterium breve 
Bifidobacterium longum  
Carnobacterium divergens 
††† 
     
Corynebacterium 
glutamicum**  
  QPS only applies when 
the species is used for 
amino acid production 
Lactobacillus acidophilus  
Lactobacillus amylolyticus  
Lactobacillus amylovorus  
Lactobacillus alimentarius  
Lactobacillus aviaries  
Lactobacillus brevis  
Lactobacillus buchneri  
Lactobacillus casei *** 
Lactobacillus cellobiosus 
Lactobacillus coryniformis 
Lactobacillus crispatus  
Lactobacillus curvatus  
Lactobacillus delbrueckii 
Lactobacillus farciminis  
Lactobacillus fermentum  
Lactobacillus gallinarum  
Lactobacillus gasseri  
Lactobacillus helveticus  
Lactobacillus hilgardii  
Lactobacillus johnsonii  
Lactobacillus 
kefiranofaciens  
Lactobacillus kefiri  
Lactobacillus mucosae  
Lactobacillus panis 
Lactobacillus collinoides 
Lactobacillus paracasei  
Lactobacillus 
paraplantarum  
Lactobacillus pentosus  
Lactobacillus plantarum  
Lactobacillus pontis  
Lactobacillus reuteri  
Lactobacillus 
rhamnosus  
Lactobacillus sakei  
Lactobacillus salivarius  
Lactobacillus 
sanfranciscensis  
 
Lactococcus lactis    
Leuconostoc citreum 
Leuconostoc 
pseudomesenteroides 
Leuconostoc lactis Leuconostoc 
mesenteroides 
 
 
Microbacterium imperiale 
††† 
  QPS only applies when 
the species is used for 
enzyme production 
Oenococcus oeni    
Pediococcus acidilactici Pediococcus dextrinicus Pediococcus 
pentosaceus 
 
Propionibacterium 
freudenreichii 
Propionibacterium 
acidipropionici 
  
Streptococcus 
thermophilus 
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Bacillus 
Species  Qualifications*  
Bacillus 
amyloliquefaciens  
Bacillus atrophaeus  
Bacillus clausii  
Bacillus coagulans  
Bacillus fusiformis 
Bacillus lentus  
Bacillus licheniformis  
Bacillus megaterium  
Bacillus mojavensis 
Bacillus pumilus  
Bacillus subtilis  
Bacillus vallismortis  
 
Absence of toxigenic 
activity. 
Geobacillus 
stearothermophilus 
  Absence of toxigenic 
activity. 
Gram-Negative Bacteria    
Species   Qualifications* 
Gluconobacter oxydans 
 
  QPS only applies when the 
species is used for vitamin 
production 
Yeasts††
 
Species  Qualifications  
Candida cylindracea †††     QPS only applies when the 
species is used for enzyme 
production 
Debaryomyces hansenii    
Hanseniaspora uvarum    
Kluyveromyces lactis Kluyveromyces marxianus   
Komagataella pastoris 
Lindnera jadinii  
Ogataea angusta 
  QPS only applies when the 
species is used for enzyme 
production 
Saccharomyces 
bayanus**** 
Saccharomyces 
cerevisiae†,**** 
Saccharomyces 
pastorianus****  
  
Schizosaccharomyces 
pombe 
   
Wickerhamomyces 
anomalus**** 
  QPS only applies when the 
species is used for enzyme 
production 
Xanthophyllomyces 
dendrorhous (imperfect 
form Phaffia rhodozyma)  
   
Virus    
Plant viruses    
Family    
Alphaflexiviridae Potyviridae   
Insect viruses    
Family    
Baculoviridae    
* Generic qualification for all QPS bacterial taxonomic units: the strains should not harbour any acquired antimicrobial 
resistance genes to clinically relevant antibiotics. 
**  Brevibacterium lactofermentum is a synonym of Corynebacterium glutamicum  
*** The previously described species ‘Lactobacillus zeae’ has been included in the species Lactobacillus casei 
**** Absence of resistance to antimycotics used for medical treatment of yeast infections in cases where viable cells are 
added to the food or feed chain. In the case of Saccharomyces cerevisiae this qualification applies for yeast strains 
able to grow above 37 °C.  
†  Saccharomyces cerevisiae, subtype boulardii is contraindicated for persons with fragile health, as well as for patients 
with a central venous catheter in place.   
††  Yeast synonyms commonly used in the feed/food industry: 
  Wickerhamomyces anomalus: synonym Hansenula anomala, Pichia anomola, Saccharomyces anomalus 
  Lindnera jadinii: synonyms Pichia jadinii, Hansenula jadinii, Torulopsis utilis 
  Saccharomyces cerevisiae synonym: Saccharomyces boulardii 
  Saccharomyces pastorianus: synonym Saccharomyces carlsbergensis 
   Komagataella pastoris: synonym Pichia pastoris 
 Ogataea angusta: synonym Pichia angusta 
 Debaromyces hansenii: synonym Candida famata 
†††      new microorganisms recommended in this Panel Statement published in December 2014 
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Appendix B.  Microbial species as notified to EFSA received (May 2013 and October 2014) 
EFSA 
Unit/Panel 
Microorganism 
species/strain  
 
Intended use EFSA Register of 
Questions and EFSA 
Journal 
Additional information provided by the 
EFSA Scientific Unit 
Previous 
QPS 
status?
 12
 
 
To be 
evaluated/ 
not 
evaluated 
Bacteria 
Feed/ 
FEEDAP 
Actinomadura roseorufa  
ATCC 53664 
Production of semduramicin 
(coccidiostat) 
EFSA-Q-2014-00219  
FAD-2014-0009 
 No Yes 
Feed/ 
FEEDAP 
Bacillus licheniformis (ATCC 
53757) 
Zootechnical feed additive EFSA-Q-2013-00630 
FAD-2013-0017 
  Yes No 
Feed/ 
FEEDAP 
Bacillus toyonensis 
(previously B. cereus var. 
toyoi) 
Zootechnical feed additive EFSA-Q-2014-00043 
 
EFSA Journal 
2014;12(7):3766, 17 pp. 
http://www.efsa.europa.eu/e
n/efsajournal/pub/3766.htm  
Already assessed in several occasions but 
now it has been reassigned to this novel 
taxonomical unit 
No Yes 
Feed/ 
FEEDAP 
Bifidobacterium animalis ssp. 
animalis  
DSM 16284 
Zootechnical feed additive EFSA-Q-2014-00224  
FAD-2014-0011 
Already assessed in EFSA-Q-2009-00823 Yes No 
Feed/ 
FEEDAP 
Carnobacterium divergens  
S1 
Zootechnical feed additive EFSA-Q-2013-00996 
FAD-2013-0048 
Very first notification of this species No Yes 
Feed/ 
FEEDAP 
Clostriduim butyricum CBM 
588 
Zootechnical feed additive EFSA-Q-2013-00594  
 
EFSA Journal 
2014;12(3):3603, 10 pp. 
http://www.efsa.europa.eu/e
n/efsajournal/pub/3603.htm  
Already assessed in several occasions No Yes 
Feed/ 
FEEDAP 
Corynebacterium glutamicum 
KCTC 10423BP 
Nutritional additives (amino 
acid) 
EFSA-Q-2014-00296      
FAD-2014-0012 
 Yes No 
Feed/ 
FEEDAP 
Enterococcus faecium  
DSM 21913 
Zootechnical feed additive EFSA-Q-2014-00224  
FAD-2014-0011 
Already assessed in EFSA-Q-2009-00823 No No 
Feed/ 
FEEDAP 
Escherichia coli/DC231 Nutritional/Production of L-
lysine sulphate 
EFSA-Q-2014-00003 
FAD-2013-0045 
 No Yes 
Feed/ 
FEEDAP 
Escherichia coli FERM BP-
10941 
Nutritional/Production of 
copper chelate of L-
EFSA-Q-2013-00407 
 
GMM 
Production strain of L-Lysine-HCl used in 
No Yes 
                                                     
12 Not present in the QPS list as published in the 2013 QPS update scientific opinion (version before the publication of this Panel statement)  
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EFSA 
Unit/Panel 
Microorganism 
species/strain  
 
Intended use EFSA Register of 
Questions and EFSA 
Journal 
Additional information provided by the 
EFSA Scientific Unit 
Previous 
QPS 
status?
 12
 
 
To be 
evaluated/ 
not 
evaluated 
Lysinate-HCl EFSA Journal 
2014;12(7):3796, 20 pp.  
http://www.efsa.europa.eu/e
n/efsajournal/pub/3796.htm 
 
EFSA-Q-2014-00496  
FAD-2014-0021 
the manufacturing of the additive 
Feed/ 
FEEDAP 
Escherichia coli K-12/ 
AG7056X 
Nutritional/Production of 
threonine 
EFSA-Q-2013-00676 
 
EFSA Journal 
2014;12(10):3825, 14 pp. 
http://www.efsa.europa.eu/e
n/efsajournal/pub/3825.htm  
 No Yes 
Feed/ 
FEEDAP 
Escherichia coli K-12/ 
AG8012X 
Nutritional/Production of 
tryptophan 
EFSA-Q-2013-00677 
 
EFSA Journal 
2014;12(10):3826, 13 pp.  
http://www.efsa.europa.eu/e
n/efsajournal/pub/3826.htm  
 No Yes 
Feed/ 
FEEDAP 
Escherichia coli K-12/ 
INTK-01X 
Nutritional/Production of 
lysine 
EFSA-Q-2013-00823 
 
EFSA Journal 
2014;12(11):3895, 20 pp.  
http://www.efsa.europa.eu/e
n/efsajournal/pub/3895.htm  
 No Yes 
Feed/ 
FEEDAP 
Escherichia coli VA-05 Nutritional additives (amino 
acid) 
EFSA-Q-2014-00299          
FAD-2014-0015 
GMM No Yes 
Feed/ 
FEEDAP 
Lactobacillus casei  
LOCK 0915 
Zootechnical feed additive EFSA-Q-2013-00996 
FAD-2013-0048 
 Yes No 
Feed/ 
FEEDAP 
Lactobacillus lactis IBB500 
Lactobacillus delbrueckii 
Zootechnical feed additive EFSA-Q-2013-00996  
FAD-2013-0048 
WG Comment: should be moved to QPS 
Lactobacillus delbrueckii 
Yes No 
Feed/ 
FEEDAP 
Lactobacillus plantarum  
LOCK 0862 
Zootechnical feed additive EFSA-Q-2013-00996  
FAD-2013-0048 
 
 Yes No 
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EFSA 
Unit/Panel 
Microorganism 
species/strain  
 
Intended use EFSA Register of 
Questions and EFSA 
Journal 
Additional information provided by the 
EFSA Scientific Unit 
Previous 
QPS 
status?
 12
 
 
To be 
evaluated/ 
not 
evaluated 
Feed/ 
FEEDAP 
Lactobacillus salivarius ssp. 
salivarius  
DSM 16351 
Zootechnical feed additive EFSA-Q-2014-00224  
FAD-2014-0011 
Already assessed in EFSA-Q-2009-00823 Yes No 
Feed/ 
FEEDAP 
Paenibacillus lentus  
DSM 28088 
Zootechnical feed additive 
Production of enzyme 
EFSA-Q-2014-00115 
FAD-2014-0001 
  No Yes 
Feed/ 
FEEDAP 
Pediococcus acidilactici 
(CNCM) MA 18/5M 
Zootechnical feed additive EFSA-Q-2014-00091  
FAD-2010-0122 
Already assessed in several occasions Yes No 
Feed/ 
FEEDAP 
Pediococcus acidilactici 
(CNCM) MA 18/5M 
Zootechnical feed additive EFSA-Q-2013-00704  
FAD-2013-0031 
Already assessed in several occasions Yes No 
Feed/ 
FEEDAP 
Streptomyces albus  
ATCC 21838 
Production of salinomycin 
sodium (coccidiostat) 
EFSA-Q-2013-00706 
FAD-2013-0029 
 
EFSA-Q-2013-00998 
FAD-2013-0053 
 
EFSA-Q-2014-00350 
FAD-2014-0016 
It will be validated end of 2014. The full 
registration number is ATCC21838/US 
9401-06 
No Yes 
Feed/ 
FEEDAP 
Streptomyces albus  
NCIMB 30321 
Production of salinomycin 
sodium (coccidiostat) 
EFSA-Q-2014-00350          
FAD-2014-0016 
It will be validated end of 2014. 
The applicant is presenting two production 
strains in the same application. 
Accordingly, one mandate has been sent 
by the EC. 
No Yes 
Feed/ 
FEEDAP 
Streptomyces aureofaciens 
NRRL 8092 
Production of narasin 
(coccidiostat) 
EFSA-Q-2013-00767 
FAD-2013-0041 
 No Yes 
Feed/ 
FEEDAP 
Streptomyces cinnamonensis 
ATCC 15413 
Production of monensin 
sodium (coccidiostat) 
EFSA-Q-2013-00752 
FAD-2013-0037 
 No Yes 
Feed/ 
FEEDAP 
Streptomyces lasaliensis  
ATCC 31180 
Production of lasalocid A 
sodium (coccidiostat) 
EFSA-Q-2013-00813 
FAD-2013-0040 
 No Yes 
FIP/CEF Bacillus subtilis MAM Production of Food Enzyme EFSA-Q-2013-00790 
FIP-2013-0071 
The food enzyme is a glucans 1,4-alpha 
glucosidase and produced by a GMM 
strain 
Yes 
 
No 
FIP/CEF Bacillus subtilis XAS Production of Food Enzyme EFSA-Q-2014-00293 
FIP-2014-0029 
 
The food enzyme is a endo 1,4-beta 
xylanase and produced by a GMM strain 
Yes No 
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EFSA 
Unit/Panel 
Microorganism 
species/strain  
 
Intended use EFSA Register of 
Questions and EFSA 
Journal 
Additional information provided by the 
EFSA Scientific Unit 
Previous 
QPS 
status?
 12
 
 
To be 
evaluated/ 
not 
evaluated 
FIP/CEF Bacillus licheniformis NZYM-
AC 
Production of Food Enzyme EFSA-Q-2013-00586 
FIP-2013-0043 
The food enzyme is an alpha-amylase 
produced by a GMM strain 
Yes 
 
No 
FIP/CEF Bacillus licheniformis NZYM-
BC 
Production of Food Enzyme EFSA-Q-2013-00685 
FIP-2013-0066 
The food enzyme is an alpha-amylase 
produced by a GMM strain 
Yes 
 
No 
FIP/CEF Bacillus licheniformis NZYM-
KE 
Production of Food Enzyme EFSA-Q-2012-00898 
FIP-2012-0051 
The food enzyme is an alpha-amylase 
produced by a GMM strain 
Yes No 
FIP/CEF Bacillus licheniformis NZYM-
RH 
Production of Food Enzyme EFSA-Q-2014-00292 
FIP-2014-0028 
The food enzyme is a Serine protease 
produced by a GMM strain 
Yes 
 
No 
FIP/CEF Microbacterium imperiale 
AE-AMT 
Production of Food Enzyme EFSA-Q-2014-00544 
FIP-2014-0063 
The food enzyme is an alpha-amylase No  Yes 
Nutrition/ 
NDA 
Pasteurised milk products 
fermented with Bacteroides 
xylanisolvens 
As a Novel Food ingredient EFSA-Q-2014-00301 
Under validation 
A safety assessment under the framework 
of Novel Foods 
No Yes 
Nutrition/ 
NDA 
A combination of four 
bacterial strains: 
Bifidobacterium longum LA 
101, Lactobacillus helveticus 
LA 102, Lactococcus lactis 
LA 103 and Streptococcus 
thermophilus LA 104 
  
Food targeted for health 
claims: “improvement of  
bowel function by increasing 
stool frequency” 
 
 
EFSA-Q-2013-00893 
 
EFSA Journal 
2014;12(5):3659, 10 pp. 
http://www.efsa.europa.eu/e
n/efsajournal/pub/3659.htm  
An intake of one sachet (2.5 g) per day for 
28 days. The concentration of the bacterial 
strains in colony forming units (CFU) is of 
10
10
 CFU/per sachet (2.9×10
9
 CFU B. 
longum LA 101; 2.9×10
9
 CFU L. 
helveticus LA 102; 2.9×10
9
 CFU L. lactis 
LA 103; 1.3×10
9
 CFU S. thermophilus LA 
104) 
In the framework of the EU Regulation 
1924/2006 on health claims made on 
foods, EFSA is only requested to perform 
efficacy assessment (i.e. relationship 
between the food consumption and the 
claimed beneficial effect). Safety 
assessment is not foreseen.  
 
 
 
 
 
 
NA No 
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EFSA 
Unit/Panel 
Microorganism 
species/strain  
 
Intended use EFSA Register of 
Questions and EFSA 
Journal 
Additional information provided by the 
EFSA Scientific Unit 
Previous 
QPS 
status?
 12
 
 
To be 
evaluated/ 
not 
evaluated 
Nutrition/ 
NDA 
Combination of four bacterial 
strains: Bifidobacterium 
longum LA 101, Lactobacillus 
helveticus LA 102, 
Lactococcus lactis LA 103  
and Streptococcus 
thermophilus LA 104  
Food targeted for health 
claims: “reducing intestinal 
discomfort”  
EFSA-Q-2013-00892 
 
EFSA Journal 
2014;12(5):3658, 10 pp. 
http://www.efsa.europa.eu/e
n/efsajournal/pub/3658.htm  
The concentration of the bacterial strains 
in colony forming units (CFU) is of 1010 
CFU/per sachet (2.9×10
9
 CFU B. longum 
LA 101; 2.9×10
9
 CFU L. helveticus LA 
102; 2.9×10
9
 CFU L. lactis LA 103; 
1.3×10
9
 CFU S. thermophilus LA 104) 
Safety assessment is not foreseen. 
 
NA No 
Nutrition/ 
NDA 
Synbio, a combination of 
Lactobacillus rhamnosus IMC 
501® and Lactobacillus 
paracasei IMC 502® 
 
  EFSA-Q-2014-00567 
0425_IT 
Notes: In the framework of the EU 
Regulation 1924/2006 on health claims 
made on foods, EFSA is only requested to 
perform efficacy assessment (i.e. 
relationship between the food consumption 
and the claimed beneficial effect). Safety 
assessment is not foreseen.  
Yes No 
Filamentous fungi 
Feed/ 
FEEDAP 
Aspergillus niger  
(CBS 18404) 
Zootechnical feed additive 
(production of enzyme) 
EFSA-Q-2013-00886  
 
EFSA Journal 
2014;12(6):3723, 9 pp. 
http://www.efsa.europa.eu/e
n/efsajournal/pub/3723.htm 
 
EFSA-Q-2014-00291 
FAD-2014-0007 
Already assessed in EFSA-Q-2008-013a No No 
Feed/ 
FEEDAP 
Aspergillus niger  
(CBS 109.713) 
Zootechnical feed additive 
(production of enzyme) 
EFSA-Q-2013-00886 
 
EFSA Journal 
2014;12(6):3723, 9 pp. 
http://www.efsa.europa.eu/e
n/efsajournal/pub/3723.htm 
   
EFSA-Q-2014-00291 
FAD-2014-0007 
Already assessed in EFSA-Q-2008-013a No No 
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EFSA 
Unit/Panel 
Microorganism 
species/strain  
 
Intended use EFSA Register of 
Questions and EFSA 
Journal 
Additional information provided by the 
EFSA Scientific Unit 
Previous 
QPS 
status?
 12
 
 
To be 
evaluated/ 
not 
evaluated 
Feed/ 
FEEDAP 
Aspergillus niger  
MUCL 39199 
Zootechnical feed additive 
(product of enzyme) 
EFSA-Q-2014-00229         
FAD-2010-0227 
  No No 
Feed/ 
FEEDAP 
Aspergillus niger  
NRRL 25541 
Zootechnical feed additive 
(product of enzyme) 
EFSA-Q-2014-00503 
FAD-2014-0019                           
EFSA-Q-2014-00504                   
FAD-2014-0018 
Already assessed in EFSA-Q2010-01519 
and EFSA-Q-2010-00585 
No No 
Feed/ 
FEEDAP 
Aspergillus niger 
Strains: ZLCA0323 
Van Tieghem ZS9 
TN-A09 
Production of Citric Acid EFSA-Q-2013-00612 
FAD-2012-0048 
  No No 
Feed/ 
FEEDAP 
Aspergillus oryzae  
DSM 17594 
Zootechnical feed additive 
(product of enzyme) 
EFSA-Q-2014-00450    
FAD-2014-0017 
GMM already assessed in EFSA-Q-2007-
133 
No No 
Feed/ 
FEEDAP 
Aspergillus oryzae  
DSM 22594 
Zootechnical feed additive 
(production of enzyme) 
EFSA-Q-2014-00289                   
FAD-2014-0008 
Already assessed in EFSA-Q-2010-00769 No No 
Feed/ 
FEEDAP 
Aspergillus oryzae  
DSM 26372 
Zootechnical feed additive 
(product of enzyme) 
EFSA-Q-2014-00447           
FAD-2013-0047 
GMM already assessed in EFSA-Q-2008-
419 
No No 
Feed/ 
FEEDAP 
Aspergillus oryzae  
NRRL 66222 
Zootechnical feed additive 
(product of enzyme) 
EFSA-Q-2014-00503 
FAD-2014-0019 
Already assessed in EFSA-Q2010-01519 No No 
Feed/ 
FEEDAP 
Penicillium funiculosum 
(Talaromyces versatilis 
sp.nov.  DSM 26702) 
Zootechnical feed additive EFSA-Q-2013-00750 
 
EFSA Journal 
2014;12(7):3793, 20 pp. 
http://www.efsa.europa.eu/e
n/efsajournal/pub/3793.htm 
 
EFSA-Q-2014-00463         
FAD-2014-0020 
 
 
 
 
 
 
 
GMM 
 
No No 
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EFSA 
Unit/Panel 
Microorganism 
species/strain  
 
Intended use EFSA Register of 
Questions and EFSA 
Journal 
Additional information provided by the 
EFSA Scientific Unit 
Previous 
QPS 
status?
 12
 
 
To be 
evaluated/ 
not 
evaluated 
Feed/ 
FEEDAP 
Penicillium funiculosum 
(Talaromyces versatilis IMI 
378536) 
Zootechnical feed additive 
(production of enzyme) 
EFSA-Q-2013-00750 
 
EFSA Journal 
2014;12(7):3793, 20 pp. 
http://www.efsa.europa.eu/e
n/efsajournal/pub/3793.htm 
 
EFSA-Q-2014-00463         
FAD-2014-0020 
Already assessed in EFSA-Q-2010-01287 No No 
Feed/ 
FEEDAP 
Trichoderma citroviridae  
(IMI SD 135) 
Zootechnical feed additive 
(production of enzyme) 
EFSA-Q-2013-00809 
FAD-2013-0046 
Already assessed in EFSA-Q-2010-00036 No No 
Feed/ 
FEEDAP 
Trichoderma citroviridae  
(IMI SD 142) 
Zootechnical feed additive 
(production of enzyme) 
EFSA-Q-2014-00297 
FAD-2014-0013 
Already assessed in EFSA-Q-2010-01025 No No 
Feed/ 
FEEDAP 
Trichoderma longibrachiatum 
MUCL 39203 
Zootechnical feed additive 
(product of enzyme) 
EFSA-Q-2014-00228 
FAD-2010-0213 
Already assessed in EFSA-Q-2008-288 No No 
Feed/ 
FEEDAP 
Trichoderma reesei   
(ATCC SD-6528) 
Zootechnical feed additive 
(production of enzyme) 
EFSA-Q-2013-00997 
FAD-2013-0049 
GMM strain No No 
FIP/CEF Aspergillus acidus/ RF7398 Production of Food Enzyme EFSA-Q-2014-00163 
FIP-2014-0020 
The food enzyme is a endo 1,4-
betaxylanase produced by a GMM strain 
No No 
FIP/CEF Aspergillus aculeatus/  
NZYM-RE  
CBS 589.94 
Production of Food Enzyme EFSA-Q-2014-00200 
FIP-2014-0024 
 
EFSA-Q-2014-00201 
FIP-2014-0025 
The food enzyme is a polygalacturonase              
The food enzyme is a betaglucanase 
No No 
FIP/CEF Aspergillus melleus/AE-DN Production of Food Enzyme EFSA-Q-2014-00326 
FIP-2014-0037 
The food enzyme is an AMP deaminase No No 
FIP/CEF Aspergillus niger  Production of Food Enzyme EFSA-Q-2013-01018 
FIP-2013-0082 
The food enzyme is a glucose oxidase and 
catalase 
No No 
FIP/CEF Aspergillus niger/AGN Production of Food Enzyme EFSA-Q-2014-00401 
FIP-2014-0059 
The food enzyme is an asparaginase 
produced by a GMM strain 
No No 
FIP/CEF Aspergillus niger/DS 53180 Production of Food Enzyme EFSA-Q-2013-00895 
FIP-2013-0077 
The food enzyme is an asparaginase 
produced by a GMM strain 
No No 
FIP/CEF Aspergillus niger/EPG Production of Food Enzyme EFSA-Q-2014-00402 
FIP-2014-0060 
The food enzyme is a polygalacturonase 
produced by a GMM strain 
No No 
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FIP/CEF Aspergillus niger/NZYM-BE Production of Food Enzyme EFSA-Q-2013-00896 
FIP-2013-0078 
The food enzyme is a glucoamylase 
produced by a GMM strain 
No No 
FIP/CEF Aspergillus niger/NZYM-BF Production of Food Enzyme EFSA-Q-2014-00307 
FIP-2014-0032 
The food enzyme is a glucoamylase 
produced by a GMM strain 
No No 
FIP/CEF Aspergillus niger/NZYM-BR Production of Food Enzyme EFSA-Q-2013-00686 
FIP-2013-0067 
The food enzyme is an amyloglucosidase 
produced by a GMM strain 
No No 
FIP/CEF Aspergillus niger/NZYM-BX Production of Food Enzyme EFSA-Q-2013-00877 
FIP-2013-0073 
The food enzyme is a glucan 1,4-alpha-
glucosidase with activity also of  an alpha 
amylase produced by a GMM strain 
No No 
FIP/CEF Aspergillus niger/NZYM-MC Production of Food Enzyme EFSA-Q-2014-00306 
FIP-2014-0031 
The food enzyme is an alpha amylase 
produced by a GMM strain 
No No 
FIP/CEF Aspergillus niger/NZYM-SB Production of Food Enzyme EFSA-Q-2014-00413 
FIP-2014-0053 
The food enzyme is an alpha-amylase  
produced by a GMM strain 
No No 
FIP/CEF Aspergillus niger/LFS Production of Food Enzyme EFSA-Q-2014-00325 
FIP-2014-0036 
The food enzyme is a tryacylglycerol 
lipase produced by a GMM strain 
No No 
FIP/CEF Aspergillus niger/XYL Production of Food Enzyme EFSA-Q-2014-00305 
FIP-2014-0030 
The food enzyme is a Endo-1,4-beta-
xylanase  produced by a GMM strain 
No No 
FIP/CEF Aspergillus niger/ZGL Production of Food Enzyme EFSA-Q-2013-01005 
FIP-2013-0080 
The food enzyme is a glucose oxidase 
produced by a GMM strain 
No No 
FIP/CEF Aspergillus oryzae/AE-TL Production of Food Enzyme EFSA-Q-2014-00112 
FIP-2014-0014 
The food enzymes are triacylglycerol 
lipase and transesterase 
No No 
FIP/CEF Aspergillus oryzae/NZYM-AL Production of Food Enzyme EFSA-Q-2013-00198 
 
EFSA Journal 
2014;12(7):3778, 2 pp. 
http://www.efsa.europa.eu/e
n/efsajournal/pub/3778.htm  
The food enzyme is a lipase produced by a 
GMM strain 
No No 
FIP/CEF Aspergillus oryzae/NZYM-FA Production of Food Enzyme EFSA-Q-2013-00789 
FIP-2013-0070 
 
 
 
 
 
The food enzyme is a xylanase produced 
by a GMM strain 
No No 
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FIP/CEF Aspergillus oryzae/NZYM-FL Production of Food Enzyme EFSA-Q-2013-00197 
 
EFSA Journal 
2014;12(7):3762, 15 pp. 
http://www.efsa.europa.eu/e
n/efsajournal/pub/3762.htm  
The food enzyme is a lipase produced by a 
GMM strain 
No No 
FIP/CEF Aspergillus oryzae/NZYM-KE Production of Food Enzyme EFSA-Q-2012-00897 
 
EFSA Journal 
2014;12(5):3645, 17 pp. 
http://www.efsa.europa.eu/e
n/efsajournal/pub/3645.htm  
The food enzyme is a xylanase produced 
by a GMM strain 
No No 
FIP/CEF Aspergillus oryzae/NZYM-KP Production of Food Enzyme EFSA-Q-2013-00687 
FIP-2013-0065 
The food enzyme is a glucose oxidase 
produced by a GMM strain 
No No 
FIP/CEF Aspergillus oryzae/ 
NZYM-LH 
Production of Food Enzyme EFSA-Q-2012-01009 
 
EFSA Journal 
2014;12(7):3763, 15 pp. 
http://www.efsa.europa.eu/e
n/efsajournal/pub/3763.htm  
The food enzyme is a lipase produced by a 
GMM strain 
No No 
FIP/CEF Aspergillus oryzae/ 
NZYM-NA 
Production of Food Enzyme EFSA-Q-2012-01010 
FIP-2013-0007 
The food enzyme is an alpha-amylase No No 
FIP/CEF Aspergillus oryzae/ 
NZYM-SP 
Production of Food Enzyme EFSA-Q-2013-00587 
FIP-2013-0044 
The food enzyme is an asparaginase 
produced by a GMM strain 
No No 
FIP/CEF Disporotrichum 
dimorphosporum/DXL 
Production of Food Enzyme EFSA-Q-2014-00355  
FIP-2014-0040 
 
EFSA-Q-2014-00356 
FIP-2014-0041 
The food enzymes  is a Endo-1,4-beta-
xylanase & beta-glucanase 
No No 
FIP/CEF Fusarium venenatum Production of Food Enzyme EFSA-Q-2014-00412 
FIP-2014-0052 
The food enzyme is a trypsin produced by 
a GMM strain 
No No 
FIP/CEF Leptographium procerum Production of Food Enzyme EFSA-Q-2013-01006 
FIP-2013-0081 
The food enzyme is a phosphodiesterase 
produced 
No No 
FIP/CEF Penicillium roqueforti AE- Production of Food Enzyme EFSA-Q-2014-00545 The food enzymes  is a triacylglycerol No No 
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LRF FIP-2014-0064 lipase 
FIP/CEF Rhyzopus oryzae/AE-MB Production of Food Enzyme EFSA-Q-2014-00114 
FIP-2014-0016 
The food enzymes are leucyl 
aminopeptidase, protease and amylase  
No No 
FIP/CEF Rhyzopus oryzae/AE-PER Production of Food Enzyme EFSA-Q-2014-00354 
FIP-2014-0038 
The food enzymes is a leucyl 
aminopeptidase  
No No 
FIP/CEF Trichoderma  citrinoviride/ 
TCLSC 
Production of Food Enzyme EFSA-Q-2014-00543 
FIP-2014-0062 
The food enzyme is an endo-1,4-β-
xylanase 
No No 
FIP/CEF Trichoderma reesei/RF5703 Production of Food Enzyme EFSA-Q-2014-00410 
FIP-2014-0050 
The food enzyme is a endo 1,4-
betaxylanase produced by a GMM strain 
No No 
FIP/CEF Trichoderma reesei/RF6199 Production of Food Enzyme EFSA-Q-2014-00164 
FIP-2014-0021 
The food enzyme is a pectine lyase No No 
FIP/CEF Trichoderma reesei/RF8793 Production of Food Enzyme EFSA-Q-2014-00411 
FIP-2014-0051 
The food enzyme is a phospholipase A2 
produced by a GMM strain 
No No 
Pesticides/ 
PPR 
Beauveria bassiana  
strain NPP111B005 
Plant protection product EFSA-Q-2014-00327   No No 
Pesticides/ 
PPR 
Beauveria bassiana  
strain 147 
Plant protection product EFSA-Q-2014-00324   No No 
Pesticides/ 
PPR 
Isaria fumosorosea  
strain Apopka 97 
Plant protection product EFSA-Q-2013-00833 
 
EFSA Journal 
2014;12(5):3679, 23 pp. 
http://www.efsa.europa.eu/e
n/efsajournal/pub/3679.htm  
It has been formerly evaluated as 
Paecilomyces fumosoroseus (DG SANCO, 
4203/VI/98-final) and approved in 2001, 
now resubmitted for renewal of the 
approval. 
No No 
Pesticides/ 
PPR 
Trichoderma atroviride SC1 Plant protection product EFSA-Q-2014-00334  No No 
Yeasts 
Feed/ 
FEEDAP 
Komagataella pastoris  
(DSMZ 25376) 
Zootechnical feed additive 
(production of enzyme) 
EFSA-Q-2013-00528 
FAD-2013-0013 
GMM 
 
Yes No 
Feed/ 
FEEDAP 
Komagataella pastoris 
(DSMZ 26469) 
Zootechnical feed additive 
(production of enzyme) 
EFSA-Q-2013-00528 
FAD-2013-0013 
GMM  Yes No 
Feed/ 
FEEDAP 
Komagataella pastoris   
(DSM 26643) 
Technological/ Production 
of fumonisine esterase 
EFSA-Q-2013-00090 
 
EFSA Journal 
2014;12(5):3667, 19 pp. 
GMM 
Synonym used: Pichia pastoris 
Yes No 
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http://www.efsa.europa.eu/e
n/efsajournal/pub/3667.htm  
Feed/ 
FEEDAP 
Saccharomyces cerevisiae 
LOCK 0141 
Zootechnical feed additive EFSA-Q-2013-00996 
FAD-2013-0048 
Not validated yet Yes No 
Feed/ 
FEEDAP 
Saccharomyces cerevisiae 
CNCM I-1077 
Zootechnical feed additive EFSA-Q-2014-00029  
FAD-2013-0054 
Already assessed in several occasions  Yes No 
Feed/ 
FEEDAP 
Saccharomyces cerevisiae 
CNCM I-1077 
Zootechnical feed additive EFSA-Q-2014-00375  
FAD-2010-0120 
Not validated yet 
Already assessed in several cases 
Yes No 
FIP/CEF Candida cylindracea  
AE-LAYH 
Production of Food Enzyme EFSA-Q-2014-00113 
FIP-2014-0015 
The food enzyme is a tryacilglycerol lipase 
by a GMM strain 
Enzymes for this microorganisms has been 
used in bakery products 
No  Yes 
FIP/CEF Saccharomyces cerevisiae 
CBS615-94 
Production of Food Enzyme EFSA-Q-2013-00119 
 
EFSA Journal 
2013;11(7):3304, 28 pp. 
http://www.efsa.europa.eu/e
n/efsajournal/pub/3304.htm  
The food enzyme is an alpha-galactosidase 
produced by a GMM strain 
Yes No 
Nutrition/ 
NDA 
Saccharomyces cerevisiae 
(vitamin D-enriched UV-
treated) 
Scientific Opinion on the 
safety of vitamin D-enriched 
UV-treated baker’s yeast 
The source for the 
production of the novel food 
ingredient is Saccharomyces 
cerevisiae  
EFSA-Q-2013-00335  
 
EFSA Journal 
2014;12(1):3520, 19 pp. 
http://www.efsa.europa.eu/e
n/efsajournal/pub/3520.htm  
Safety assessment 
As a novel food ingredient in the context 
of Regulation (EC) No 258/97 
Yes 
 
No 
Virus 
Pesticides/ 
PPR 
Pepino mosaic virus, strain 
CH2, isolate 1906 
Plant protection product EFSA-Q-2014-00054  Yes No 
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ABBREVIATIONS 
 
CEF EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
FEED EFSA Feed Unit 
FEEDAP EFSA Panel on Additives and Products or Substances used in Animal Feed 
FIP EFSA Food ingredients and packaging Unit 
IJSEM International Journal of Systematic and Evolutionary Microbiology 
LPSN    List of prokariotic names with standing in nomenclature 
NDA EFSA Panel on Dietetic Products, Nutrition and Allergies 
NUTRI EFSA Nutrition Unit 
PPR Panel on Plant Protection Products and their Residues 
PRAS EFSA Pesticides Unit 
QPS Qualified Presumption of Safety 
ToR Term of Reference 
 
